,address1,address2,city,state,zip,country,phone,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,impliedSharesOutstanding,bookValue,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,11682 El Camino Real,Suite 300,San Diego,CA,92130,United States,858 997 2400,https://www.adamispharmaceuticals.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.",11,"{'maxAge': 1, 'name': 'Mr. David J. Marguglio', 'age': 52, 'title': 'Co-Founder, Interim CFO. Pres & COO', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 526350, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7685,0.75,0.75,0.7899,0.7685,0.75,0.75,0.7899,0.0,1.277662,-9.6875,119482,119482,2180497,146235,146235,0.0,0.0,800,900,7253325,0.67,26.179998,1.4444072,1.3301252,6.964481,0.0,0.0,USD,7276099,0.0,9144996,9359130,98936,57653,1689292800,1692057600,0.012999999,0.07811,0.16589001,0.02,0.012999999,9359130,-4.238,1672444800,1703980800,1688083200,-23864894,-10.14,-0.08,1:70,1684713600,1.449,-0.409,-0.9722085,0.14113986,NCM,EQUITY,ADMP,ADMP,Adamis Pharmaceuticals Corporat,Adamis Pharmaceuticals Corporation,808407000,America/New_York,EDT,b7edb701-4a7f-3138-bcca-88c77fca2015,finmb_41081420,-14400000,0.775,3.0,hold,640254,0.068,-17794120,332436,0.044,0.23,5021662,2.222,-1.04495,-1431408,-1705458,-13143957,-0.826,-0.2315,0.0,-3.7361999,USD,
1,11682 El Camino Real,Suite 300,San Diego,CA,92130,United States,858 997 2400,https://www.adamispharmaceuticals.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.",11,"{'maxAge': 1, 'name': 'Dr. Ebrahim  Versi M.D., Ph.D.', 'age': 69, 'title': 'CEO & Chair of the Board', 'yearBorn': 1953, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7685,0.75,0.75,0.7899,0.7685,0.75,0.75,0.7899,0.0,1.277662,-9.6875,119482,119482,2180497,146235,146235,0.0,0.0,800,900,7253325,0.67,26.179998,1.4444072,1.3301252,6.964481,0.0,0.0,USD,7276099,0.0,9144996,9359130,98936,57653,1689292800,1692057600,0.012999999,0.07811,0.16589001,0.02,0.012999999,9359130,-4.238,1672444800,1703980800,1688083200,-23864894,-10.14,-0.08,1:70,1684713600,1.449,-0.409,-0.9722085,0.14113986,NCM,EQUITY,ADMP,ADMP,Adamis Pharmaceuticals Corporat,Adamis Pharmaceuticals Corporation,808407000,America/New_York,EDT,b7edb701-4a7f-3138-bcca-88c77fca2015,finmb_41081420,-14400000,0.775,3.0,hold,640254,0.068,-17794120,332436,0.044,0.23,5021662,2.222,-1.04495,-1431408,-1705458,-13143957,-0.826,-0.2315,0.0,-3.7361999,USD,
2,11682 El Camino Real,Suite 300,San Diego,CA,92130,United States,858 997 2400,https://www.adamispharmaceuticals.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.",11,"{'maxAge': 1, 'name': 'Ms. Jennifer C. Suski', 'title': 'Sr. Director of Marketing', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7685,0.75,0.75,0.7899,0.7685,0.75,0.75,0.7899,0.0,1.277662,-9.6875,119482,119482,2180497,146235,146235,0.0,0.0,800,900,7253325,0.67,26.179998,1.4444072,1.3301252,6.964481,0.0,0.0,USD,7276099,0.0,9144996,9359130,98936,57653,1689292800,1692057600,0.012999999,0.07811,0.16589001,0.02,0.012999999,9359130,-4.238,1672444800,1703980800,1688083200,-23864894,-10.14,-0.08,1:70,1684713600,1.449,-0.409,-0.9722085,0.14113986,NCM,EQUITY,ADMP,ADMP,Adamis Pharmaceuticals Corporat,Adamis Pharmaceuticals Corporation,808407000,America/New_York,EDT,b7edb701-4a7f-3138-bcca-88c77fca2015,finmb_41081420,-14400000,0.775,3.0,hold,640254,0.068,-17794120,332436,0.044,0.23,5021662,2.222,-1.04495,-1431408,-1705458,-13143957,-0.826,-0.2315,0.0,-3.7361999,USD,
3,11682 El Camino Real,Suite 300,San Diego,CA,92130,United States,858 997 2400,https://www.adamispharmaceuticals.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.",11,"{'maxAge': 1, 'name': 'Mr. Eddie Wabern Glover', 'age': 72, 'title': 'Chief Exec. Officer of US Compounding Inc', 'yearBorn': 1950, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7685,0.75,0.75,0.7899,0.7685,0.75,0.75,0.7899,0.0,1.277662,-9.6875,119482,119482,2180497,146235,146235,0.0,0.0,800,900,7253325,0.67,26.179998,1.4444072,1.3301252,6.964481,0.0,0.0,USD,7276099,0.0,9144996,9359130,98936,57653,1689292800,1692057600,0.012999999,0.07811,0.16589001,0.02,0.012999999,9359130,-4.238,1672444800,1703980800,1688083200,-23864894,-10.14,-0.08,1:70,1684713600,1.449,-0.409,-0.9722085,0.14113986,NCM,EQUITY,ADMP,ADMP,Adamis Pharmaceuticals Corporat,Adamis Pharmaceuticals Corporation,808407000,America/New_York,EDT,b7edb701-4a7f-3138-bcca-88c77fca2015,finmb_41081420,-14400000,0.775,3.0,hold,640254,0.068,-17794120,332436,0.044,0.23,5021662,2.222,-1.04495,-1431408,-1705458,-13143957,-0.826,-0.2315,0.0,-3.7361999,USD,
4,11682 El Camino Real,Suite 300,San Diego,CA,92130,United States,858 997 2400,https://www.adamispharmaceuticals.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.",11,"{'maxAge': 1, 'name': 'Mr. Robert B. Rothermel', 'age': 78, 'title': 'Consultant', 'yearBorn': 1944, 'fiscalYear': 2019, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7685,0.75,0.75,0.7899,0.7685,0.75,0.75,0.7899,0.0,1.277662,-9.6875,119482,119482,2180497,146235,146235,0.0,0.0,800,900,7253325,0.67,26.179998,1.4444072,1.3301252,6.964481,0.0,0.0,USD,7276099,0.0,9144996,9359130,98936,57653,1689292800,1692057600,0.012999999,0.07811,0.16589001,0.02,0.012999999,9359130,-4.238,1672444800,1703980800,1688083200,-23864894,-10.14,-0.08,1:70,1684713600,1.449,-0.409,-0.9722085,0.14113986,NCM,EQUITY,ADMP,ADMP,Adamis Pharmaceuticals Corporat,Adamis Pharmaceuticals Corporation,808407000,America/New_York,EDT,b7edb701-4a7f-3138-bcca-88c77fca2015,finmb_41081420,-14400000,0.775,3.0,hold,640254,0.068,-17794120,332436,0.044,0.23,5021662,2.222,-1.04495,-1431408,-1705458,-13143957,-0.826,-0.2315,0.0,-3.7361999,USD,
